-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45

Benzinga·11/06/2026 14:27:04
Piper Sandler analyst Jessica Tassan maintains Oscar Health (NYSE:OSCR) with a Overweight and lowers the price target from $48 to $45.